The impact of common germline risk on somatic alterations and clinical features across cancers

被引：0
|
作者：
Saito, Yuki [1 ,2 ]
Namba, Shinichi [3 ]
Kogure, Yasunori [1 ]
Okada, Yukinori [3 ,4 ,5 ]
Kataoka, Keisuke [1 ,6 ]
机构：
[1] Natl Canc Ctr, Div Mol Oncol, Res Inst, Tokyo, Japan
[2] Keio Univ, Dept Gastroenterol, Sch Med, Tokyo, Japan
[3] Osaka Univ, Dep Stat Genet, Grad Sch Med, Osaka, Japan
[4] RIKEN Ctr Integrat Med Sci, Lab Syst Genet, Yokohama, Japan
[5] Univ Tokyo, Grad Sch Med, Dept Cell Signal, Tokyo, Japan
[6] Keio Univ, Div Hematol, Dept Med, Sch Med, Tokyo, Japan
来源：
CANCER SCIENCE | 2023年 / 114卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
S8-5
引用
收藏
页码：230 / 230
页数：1
相关论文
共 50 条
  • [41] Germline mutations and pathological features of breast and female genital cancers in increased-risk patients of Asian origin
    Zaakouk, M.
    Longworth, A.
    Hoffman, J.
    Sharma-Oates, A.
    Huber, C.
    Ong, K.
    Hart, R.
    Wallis, Y.
    Considine, A.
    Dasani, P.
    Ganesan, R.
    Tomlinson, I.
    Sundar, S.
    Shaaban, A.
    VIRCHOWS ARCHIV, 2020, 477 : S8 - S8
  • [42] Clinical impact of somatic alterations in prostate cancer patients with and without previously known germline BRCA1/2 mutations: Results from PROREPAIR-A study
    Lozano Mejorada, R.
    Castro Marcos, E.
    Aragon, I. M.
    Thorne, H.
    Lopez Campos, F.
    Sanz, A.
    Alonso, C.
    Anido, U.
    Juan Fita, M. J.
    Gutierrez Pecharroman, A. M.
    Ramirez-Backhaus, M.
    Balmana, J.
    Chirivella Gonzalez, I.
    Llort, G.
    Romero Laorden, N.
    Arevalo Lobera, S.
    Rubio Briones, J.
    Pritchard, C. C.
    Sandhu, S.
    Olmos Hidalgo, D.
    ANNALS OF ONCOLOGY, 2020, 31 : S509 - S510
  • [43] Metabolic gene alterations impact the clinical aggressiveness and drug responses of 32 human cancers
    Musalula Sinkala
    Nicola Mulder
    Darren Patrick Martin
    Communications Biology, 2
  • [44] Metabolic gene alterations impact the clinical aggressiveness and drug responses of 32 human cancers
    Sinkala, Musalula
    Mulder, Nicola
    Martin, Darren Patrick
    COMMUNICATIONS BIOLOGY, 2019, 2 (1)
  • [45] Cell cycle gene alterations associate with a redistribution of mutation risk across chromosomal domains in human cancers
    Salvadores, Marina
    Supek, Fran
    NATURE CANCER, 2024, 5 (02) : 330 - 346
  • [46] Germline alterations in cancer susceptibility genes in women with high-risk bladder cancer: Implications for germline testing and clinical management.
    Truong, Hong
    Sheikh, Rania
    Khurram, Aliya
    Kemel, Yelena
    Lenis, Andrew Thomas
    Reisz, Peter
    Joseph, Vijai
    Goh, Alvin
    Cha, Eugene K.
    Donahue, Timothy F.
    Coleman, Jonathan
    Pietzak, Eugene J.
    Bochner, Bernard H.
    Offit, Kenneth
    Carlo, Maria Isabel
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (06)
  • [47] Cell cycle gene alterations associate with a redistribution of mutation risk across chromosomal domains in human cancers
    Marina Salvadores
    Fran Supek
    Nature Cancer, 2024, 5 : 330 - 346
  • [48] Variation in liquid biopsy cfDNA yield predicted by somatic mutation and clinical phenotypes across primary cancers.
    Bubie, Adrian
    Jiang, Tingting
    Gaile, Daniel
    Hutchins, Jamie
    Drusbosky, Leylah
    Kiedrowski, Lesli A.
    Chuang, Han-Yu
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [49] Concurrent ALK/EGFR Alterations in Chinese Lung Cancers: Frequency, Clinical Features, and Differential Response to Therapy
    Wu, D.
    Liu, J.
    Mu, Z.
    Liu, L.
    Li, K.
    Jiang, R.
    Chen, P.
    Zhou, Q.
    Jin, M.
    Ma, Y.
    Xie, Y.
    Xiang, J.
    Zhang, T.
    Li, B.
    Yu, B.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S500 - S500
  • [50] Concurrent ALK/EGFR Alterations in Chinese Lung Cancers: Frequency, Clinical Features, and Differential Response to Therapy
    Wu, D.
    Liu, J.
    Mu, Z.
    Liu, L.
    Li, K.
    Jiang, R.
    Chen, P.
    Zhou, Q.
    Jin, M.
    Ma, Y.
    Xie, Y.
    Xiang, J.
    Zhang, T.
    Li, B.
    Yu, B.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (12) : S1054 - S1054
12345